Sun Pharma Advanced Research Company balance sheet

As of Mar 2026

Total assets: ₹2,171cr+547.0% on Mar 2025
Shareholders' equity: ₹1,339cr−₹217 cr in Mar 2025
Total debt: ₹556cr+115.4% on Mar 2025
Cash and investments: ₹1.2cr−40.8% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	85.2	98.7	107	105
	0.5	0.6	1.3	1.9
	0.1	0.1	0.2	0.3
	71.2	53.6	42.5	25.1
	28.7	26.1	25.5	27.4
	28.7	26.1	25.5	—
	2.3	2.3	1.3	0.0
	120	128	67.6	—
	308	309	246	375
	0.0	0.0	1.8	291
	8.3	16.1	15.5	32.7
	1.2	2.0	5.3	0.6
	0.0	0.0	150	111
	0.2	0.2	0.2	0.5
	1.5	2.4	42.8	4.2
	11.1	20.5	216	440
	1,846	5.7	53.7	15.1
	1,862	26.2	269	455
	2,171	336	515	830
Equity
	32.5	32.5	32.5	32.5
	1,306	−249	93.3	480
	1,339	−217	126	513
	1,339	−217	126	513
Liabilities
	0.0	100	0.0	—
	3.0	8.0	14.7	—
	3.0	108	14.7	—
	12.3	7.7	6.1	8.1
	62.6	62.6	104	118
	78.0	178	124	138
	556	158	47.0	75.0
	97.2	114	142	146
	79.7	41.7	46.8	11.7
	733	314	236	160
	12.9	7.5	12.2	6.5
	0.0	0.4	1.7	—
	8.2	52.6	15.1	9.4
	754	374	265	179
	832	552	389	317
	2,171	336	515	830
Assets — additional as-filed lines
	5.5	0.0	0.0	—
Trade payables — MSME split
	1.3	0.9	—	—
	95.9	113	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

SPARC₹182.98

Sun Pharma Advanced Research Company Ltd.

· Pharma & Health

₹ CrorePeersSTAR SHILPAMED SUPRIYA THYROCARE RUBICON VIYASH YATHARTH PARKHOSPSMcap ₹5,938 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	105.4	107.4	98.7	85.2	85.2
+ Capital Work-in-Progress	1.9	1.3	0.6	0.5	0.5
+ Other Intangibles	0.3	0.2	0.1	0.1	0.1
+ Intangibles under Development	25.1	42.5	53.6	71.2	71.2
+ Other Non-current Financial Assets	27.4	25.5	26.1	28.7	28.7
Non-current Financial Assets	—	25.5	26.1	28.7	28.7
+ Deferred Tax Assets	0.0	1.3	2.3	2.3	2.3
+ Other Non-current Assets	—	67.6	128.0	120.4	120.4
Total Non-current Assets	375.2	245.7	309.3	308.4	308.4
Current Assets
+ Current Investments	290.9	1.8	0.0	0.0	0.0
+ Trade Receivables	32.7	15.5	16.1	8.3	8.3
+ Cash & Cash Equivalents	0.6	5.3	2.0	1.2	1.2
+ Other Bank Balances	111.0	150.0	0.0	0.0	0.0
+ Short-term Loans	0.5	0.2	0.2	0.2	0.2
+ Other Current Financial Assets	4.2	42.8	2.4	1.5	1.5
Current Financial Assets	439.9	215.7	20.5	11.1	11.1
+ Other Current Assets	15.1	53.7	5.7	1,845.9	1,845.9
Total Current Assets	455.0	269.4	26.2	1,862.4	1,862.4
Total Assets	830.1	515.0	335.5	2,170.9	2,170.9
Equity
+ Equity Share Capital	32.5	32.5	32.5	32.5	32.5
+ Other Equity / Reserves	480.3	93.3	-249.4	1,306.4	1,306.4
Equity — Owners of Parent	512.8	125.8	-217.0	1,338.8	1,338.8
Total Equity	512.8	125.8	-217.0	1,338.8	1,338.8
Liabilities
+ Borrowings — Non-current	—	0.0	100.0	0.0	0.0
+ Other Non-current Financial Liab	—	14.7	8.0	3.0	3.0
Non-current Financial Liabilities	—	14.7	108.0	3.0	3.0
+ Provisions — Non-current	8.1	6.1	7.7	12.3	12.3
+ Other Non-current Liabilities	117.6	103.5	62.6	62.6	62.6
Non-current Liabilities	138.4	124.2	178.2	78.0	78.0
+ Borrowings — Current	75.0	47.0	158.2	556.1	556.1
+ Trade Payables	146.0	142.3	113.9	97.2	97.2
+ Other Current Financial Liab	11.7	46.8	41.7	79.7	79.7
Current Financial Liabilities	160.0	236.1	313.8	733.0	733.0
+ Provisions — Current	6.5	12.2	7.5	12.9	12.9
+ Current Tax Liabilities	—	1.7	0.4	0.0	0.0
+ Other Current Liabilities	9.4	15.1	52.6	8.2	8.2
Current Liabilities	178.9	265.1	374.2	754.1	754.1
Total Liabilities	317.4	389.3	552.5	832.0	832.0
Total Equity & Liabilities	830.1	515.0	335.5	2,170.9	2,170.9
Assets — additional as-filed lines
+ Current Tax Assets	—	0.0	0.0	5.5	5.5
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	0.9	1.3	1.3
+ Dues to Other Creditors — Current	—	—	113.0	95.9	95.9

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.